Ayala Pharmaceuticals, Inc. Income Tax Expense (Benefit) in USD from Q2 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Ayala Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q4 2023.
  • Ayala Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2023 was $103K, a 37.3% increase year-over-year.
  • Ayala Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2023 was -$3.91M, a 770% decline year-over-year.
  • Ayala Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was -$3.91M, a 770% decline from 2022.
  • Ayala Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $584K, a 1068% increase from 2021.
  • Ayala Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $50K, unchanged from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

Ayala Pharmaceuticals, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$3.91M $103K +$28K +37.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$3.94M $65K -$41K -38.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$3.9M $127K -$87K -40.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$3.81M -$4.21M -$4.4M -2326% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-23
Q4 2022 $584K $75K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 $106K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $214K +$164K +328% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $189K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-23
Q2 2021 $50K May 1, 2021 Jul 31, 2021 10-Q 2022-09-13
Q1 2020 $50K Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-14
Q4 2018 $50K $0 0% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-13
Q4 2017 $50K $0 0% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-12
Q4 2016 $50K +$35.8K +251% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-12
Q4 2015 $14.2K Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-10
Q4 2013 -$626K -$626K +$99.6K +13.7% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-13
Q3 2013 -$725K $0 $0 Aug 1, 2013 Oct 31, 2013 10-K 2015-01-06
Q2 2013 -$725K $0 $0 May 1, 2013 Jul 31, 2013 10-Q 2013-09-16
Q1 2013 -$725K $0 $0 Feb 1, 2013 Apr 30, 2013 10-Q 2013-06-14
Q4 2012 -$725K -$725K -$378K -109% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 -$347K $0 $0 Aug 1, 2012 Oct 31, 2012 10-K 2014-01-29
Q2 2012 -$347K $0 $0 May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 -$347K $0 $0 Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 -$347K -$347K +$32.7K +8.61% Nov 1, 2011 Jan 31, 2012 10-Q/A 2013-03-25
Q3 2011 -$379K $0 Aug 1, 2011 Oct 31, 2011 10-K/A 2013-02-14
Q2 2011 $0 $0 May 1, 2011 Jul 31, 2011 10-Q/A 2012-10-04
Q1 2011 $0 Feb 1, 2011 Apr 30, 2011 10-Q/A 2012-10-18
Q4 2010 -$379K Nov 1, 2010 Jan 31, 2011 10-Q/A 2012-10-18
Q2 2010 $0 May 1, 2010 Jul 31, 2010 10-Q 2011-09-12

Ayala Pharmaceuticals, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3.91M -$4.5M -770% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 $584K +$534K +1068% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $50K $0 0% Nov 1, 2020 Oct 31, 2021 10-K 2023-02-10
2020 $50K $0 0% Nov 1, 2019 Oct 31, 2020 10-K 2022-02-14
2019 $50K $0 0% Nov 1, 2018 Oct 31, 2019 10-K 2021-01-22
2018 $50K +$4.45M Nov 1, 2017 Oct 31, 2018 10-K 2019-12-20
2017 -$4.4M -$1.87M -73.6% Nov 1, 2016 Oct 31, 2017 10-K 2019-01-11
2016 -$2.54M -$926K -57.6% Nov 1, 2015 Oct 31, 2016 10-K 2017-12-21
2015 -$1.61M +$748K +31.7% Nov 1, 2014 Oct 31, 2015 10-K 2017-12-21
2014 -$2.36M -$1.63M -225% Nov 1, 2013 Oct 31, 2014 10-K 2017-01-09
2013 -$725K -$378K -109% Nov 1, 2012 Oct 31, 2013 10-K 2015-01-06
2012 -$347K +$32.7K +8.61% Nov 1, 2011 Oct 31, 2012 10-K 2014-01-29
2011 -$379K -$100K -36% Nov 1, 2010 Oct 31, 2011 10-K/A 2013-02-14
2010 -$279K Nov 1, 2009 Oct 31, 2010 10-K 2012-01-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.